PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25544427-4	2015	Silencing of IL-6 using IL-6 siRNA was found to suppress IL-6 production, STAT3 and phosphoSTAT3 levels, which eventually reduced proliferation and clonogenicity of taxol-resistant SKOV3/TR cells.	Paclitaxel	165-170	interleukin 6	Homo sapiens	13-17	
25544427-4	2015	Silencing of IL-6 using IL-6 siRNA was found to suppress IL-6 production, STAT3 and phosphoSTAT3 levels, which eventually reduced proliferation and clonogenicity of taxol-resistant SKOV3/TR cells.	Paclitaxel	165-170	interleukin 6	Homo sapiens	24-28	
25544427-4	2015	Silencing of IL-6 using IL-6 siRNA was found to suppress IL-6 production, STAT3 and phosphoSTAT3 levels, which eventually reduced proliferation and clonogenicity of taxol-resistant SKOV3/TR cells.	Paclitaxel	165-170	interleukin 6	Homo sapiens	24-28	
25544427-5	2015	In addition, stattic, a STAT3 inhibitor, was found to result in decrease of cell viability and clonogenicity of these cells, indicating that the elevated IL-6 and STAT3, phosphoSTAT3 levels are associated with the development of taxol resistance.	Paclitaxel	229-234	interleukin 6	Homo sapiens	154-158	
25544427-10	2015	Taken together, our data suggest that inhibition of IL-6/STAT3 signaling pathway and downregulation of Axl and Tyro3 RTKs expression might be a therapeutic strategy to overcome taxol resistance in ovarian cancer cells.	Paclitaxel	177-182	interleukin 6	Homo sapiens	52-56